References
- 1. Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195(5):557-82. DOI: 10.1164/rccm.201701-0218PP
- 2. Lopez AD, Murray CC. The global burden of disease, 1990-2020. Nat Med. 1998;4(11):1241-3. DOI: 10.1038/3218
- 3. Mannino DM, Higuchi K, Yu TC, Zhou H, Li Y, Tian H, et al. Economic burden of COPD in the presence of comorbidities. Chest. 2015;148(1):138-50. DOI: 10.1378/chest.14-2434
- 4. Beijers RJ, Gosker HR, Schols AM. Resveratrol for patients with chronic obstructive pulmonary disease: hype or hope? Curr Opin Clin Nutr Metab Care. 2018;21(2):138-44. DOI: 10.1097/MCO.0000000000000444
- 5. Gangemi S, Casciaro M, Trapani G, Quartuccio S, Navarra M, Pioggia G, et al. Association between HMGB1 and COPD: a systematic review. Mediat Inflamm 2015;21:164913. DOI: 10.1155/2015/164913
- 6. Patel AR, Singh S, Khawaja I. Global initiative for chronic obstructive lung disease: the changes made. Cureus. 2019;11(6):e4985. DOI: 10.7759/cureus.4985
- 7. Konietzke P, Jobst B, Wagner WL, Jarosch I, Graber R, Kenn K, et al. Similarities in the computed tomography appearance in α1-antitrypsin deficiency and smoking-related chronic obstructive pulmonary disease in a smoking collective. Respiration. 2018;96(3):231-39. DOI: 10.1159/000489177
- 8. Nie XH, Jiang C, Li XM. Effect of smoking on pulmonary function of male patients with chronic obstructive pulmonary disease and their correlation. West China Med J. 2017;32:852-56.
- 9. Guiedem E, Ikomey GM, Nkenfou C, Walter PY, Mesembe M, et al. Chronic obstructive pulmonary disease (COPD): neutrophils, macrophages and lymphocytes in patients with anterior tuberculosis compared to tobacco related COPD. BMC Res Notes. 2018;11(1):192. DOI: 10.1186/s13104-018-3309-6
- 10. Lin FH, Zhang, HTan CM. The inflammatory response of elastin peptides in chronic obstructive pulmonary disease. Zhonghua Jie He He Hu Xi Za Zhi. 2018;41(6):496-98.
- 11. Ignatova GL, Antonov VN. Impact of vaccination on the course of bronchial and systemic inflammation in patients with COPD and CHD. Terapevt Arkh. 2017;89(3):29-33. DOI: 10.17116/terarkh201789329-33
- 12. Cheng Y, Wang D, Wang B, Li H, Xiong J, Xu S, et al. HMGB1 translocation and release mediate cigarette smoke-induced pulmonary inflammation in mice through a TLR4/MyD88-dependent signaling pathway. Mol Biol Cell. 2017;28(1):201-09. DOI: 10.1091/mbc. e16-02-0126
- 13. Yates KP, Deppe R, Comerford M, Masuoka H, Cummings OW, Tonascia J, et al. Serum high mobility group box 1 protein levels are not associated with either histological severity or treatment response in children and adults with nonalcoholic fatty liver disease. Plos One. 2017;12(11):e0185813. DOI: 10.1371/journal. pone.0185813
- 14. Zhang XF, Qin Q, Geng WY, Jiang CW, Liu Y, Liu XL, et al. Electroacupuncture reduces hypothalamic and medullary expression of orexins and their receptors in a rat model of chronic obstructive pulmonary disease. Acupunct Med. 2018;36(5):312-18. DOI: 10.1136/acupmed-2017-011391
- 15. Abolhalaj M, Askmyr D, Sakellariou CA, Lundberg K, Greiff L, Lindstedt M. Profiling dendritic cell subsets in head and neck squamous cell tonsillar cancer and benign tonsils. Sci Rep 2018;8(1):8030. DOI: 10.1038/s41598-018-26193-y
- 16. Jiang YQ, Wu HY and Wen YQ. Detection and clinical significance of pathogen distribution and immune function in patients with AECOPD. J Parasit Biol. 2019;14:213-16.
- 17. Huțanu A, Georgescu AM, Andrejkovits AV, Au W, Dobreanu M. Insights into Innate Immune Response Against SARS-CoV-2 Infection. Rev Romana Med Lab. 2021;29(3):255-69. DOI:10.2478/rrlm-2021-0022 DOI: 10.2478/rrlm-2021-0022
- 18. Wechsler ME. Current and emerging biologic therapies for asthma and COPD. Respir Care. 2018;63(6):699-707. DOI: 10.4187/respcare.06322
- 19. Xiong Y, Gao S, Luo G, Cheng G, Huang W, Jiang R, et al. Increased circulating autoantibodies levels of IgG, IgA, IgM against cytokeratin 18 and cytokeratin 19 in chronic obstructive pulmonary disease. Arch Med Res. 2017;48(1):79-87. DOI: 10.1016/j.arcmed.2017.01.007